Home > Healthcare > Medical Devices > Diagnostic Devices > Enteric Disease Testing Market

Enteric Disease Testing Market Size

  • Report ID: GMI4024
  • Published Date: Feb 2024
  • Report Format: PDF

Enteric Disease Testing Market Size

Enteric Disease Testing Market size was valued at around USD 3.7 billion in 2023 and is estimated to expand at 3.9% CAGR from 2024 to 2032. This high market growth can be primarily attributed to numerous factors including increasing prevalence of enteric diseases, growing concerns about food safety, continuous advancements in diagnostic technologies, and increasing healthcare expenditure and awareness across the globe.

 

Moreover, enteric diseases, which are infections of the gastrointestinal system caused by bacteria, viruses, or parasites, are prevalent across the world. Enteric diseases can be transmitted by contaminated food and water sources, inadequate sanitation, and close human-to-human contact. The growing prevalence of enteric infections demands accurate diagnostic tests to identify the causative agents, advise proper therapy, and prevent future transmission.
 

For instance, as per the stats reported by Centers for Disease Control and Prevention, in 2022 there were an estimated 9.4 million diseases, 56,000 hospital admissions, and 1,350 fatalities in the U.S. attributed to infections from major foodborne pathogens.
 

Moreover, public health surveillance systems are crucial in monitoring the prevalence, and trends of enteric disease on an individual, national, and globally scale. Surveillance data reveal insights into disease outbreaks, new pathogens, antibiotic resistance patterns, and healthcare use trends, allowing for prompt interventions and resource allocation methods. Enteric disease testing is a critical component of public health surveillance activities, enabling early diagnosis, containment, and control of infectious diseases, thereby contribute to the growth of the enteric disease testing market.
 

Enteric disease testing refers to the diagnostic evaluation conducted to identify infections and illnesses affecting the gastrointestinal tract, commonly known as the enteric system. The enteric system encompasses various organs and structures involved in the digestion and absorption of food, including the stomach, small intestine, large intestine (colon), rectum, and anus.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Enteric disease testing industry size reached USD 3.7 billion in 2023 and is set to expand at 3.9% CAGR from 2024-2032 driven by the rising prevalence of enteric diseases, growing concerns about food safety, and increasing healthcare expenditure and awareness across the globe.

Enteric disease testing industry from the immunoassay segment is anticipated to witness high demand accounting for USD 1.9 billion in revenue by 2032 as they provide rapid results compared to traditional culture-based methods or molecular diagnostics.

North America enteric disease testing industry size generated USD 1.4 billion in 2023 and is set to expand at a robust CAGR through 2032 owing to the presence of a sophisticated healthcare infrastructure, cutting-edge laboratory facilities, and well-equipped clinical microbiology laboratories.

Some of the leading enteric disease testing companies are Abbott Laboratories, Becton, Dickinson, and Company, Biomerica, Inc., BIOMÉRIEUX S.A, Bio, Rad Laboratories, Inc., Cepheid, DiaSorin S.p.A., Eurofins Scientific SE, Merck KGaA, Meridian Bioscience, and Quest Diagnostics Incorporated.

Enteric Disease Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 397
  • Countries covered: 22
  • Pages: 228
 Download Free Sample